A detailed history of Bank Of New York Mellon Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Bank Of New York Mellon Corp holds 17,065,573 shares of ABBV stock, worth $3.04 Billion. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,065,573
Previous 17,528,854 2.64%
Holding current value
$3.04 Billion
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$163.84 - $199.33 $75.9 Million - $92.3 Million
-463,281 Reduced 2.64%
17,065,573 $0
Q2 2024

Jul 25, 2024

SELL
$154.79 - $180.76 $357 Million - $417 Million
-2,304,233 Reduced 11.62%
17,528,854 $0
Q1 2024

Apr 25, 2024

SELL
$159.82 - $182.1 $363 Million - $414 Million
-2,271,404 Reduced 10.28%
19,833,087 $0
Q4 2023

Jan 29, 2024

BUY
$137.6 - $154.97 $241 Million - $271 Million
1,748,419 Added 8.59%
22,104,491 $0
Q3 2023

Oct 24, 2023

BUY
$133.59 - $154.65 $47.1 Million - $54.6 Million
352,817 Added 1.76%
20,356,072 $0
Q2 2023

Aug 03, 2023

SELL
$132.51 - $164.9 $24.5 Million - $30.5 Million
-184,804 Reduced 0.92%
20,003,255 $0
Q1 2023

May 09, 2023

BUY
$144.61 - $166.54 $2.92 Billion - $3.36 Billion
20,188,059 New
20,188,059 $0
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $2.8 Billion - $3.36 Billion
20,242,129 New
20,242,129 $3.27 Billion
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $80.4 Million - $92.2 Million
-598,934 Reduced 2.81%
20,689,448 $2.78 Billion
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $204 Million - $259 Million
1,479,757 Added 7.47%
21,288,382 $3.26 Billion
Q1 2022

May 11, 2022

SELL
$131.98 - $163.75 $208 Million - $258 Million
-1,576,202 Reduced 7.37%
19,808,625 $3.21 Billion
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $31.6 Million - $40 Million
294,359 Added 1.4%
21,384,827 $2.9 Billion
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $10.1 Million - $11.5 Million
94,954 Added 0.45%
21,090,468 $2.28 Billion
Q2 2021

Aug 11, 2021

BUY
$105.21 - $117.21 $41.4 Million - $46.2 Million
393,894 Added 1.91%
20,995,514 $2.36 Billion
Q1 2021

May 13, 2021

SELL
$102.3 - $112.62 $16.5 Million - $18.2 Million
-161,545 Reduced 0.78%
20,601,620 $2.23 Billion
Q4 2020

Feb 09, 2021

SELL
$80.49 - $108.67 $22.1 Million - $29.8 Million
-274,114 Reduced 1.3%
20,763,165 $2.22 Billion
Q3 2020

Nov 12, 2020

SELL
$85.91 - $100.83 $30.1 Million - $35.3 Million
-350,284 Reduced 1.64%
21,037,279 $1.84 Billion
Q2 2020

Aug 12, 2020

BUY
$73.37 - $98.18 $205 Million - $275 Million
2,797,448 Added 15.05%
21,387,563 $2.1 Billion
Q1 2020

May 06, 2020

BUY
$64.5 - $97.79 $224 Million - $340 Million
3,480,190 Added 23.03%
18,590,115 $1.42 Billion
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $48.9 Million - $61.2 Million
-678,062 Reduced 4.29%
15,109,925 $1.34 Billion
Q3 2019

Nov 07, 2019

SELL
$62.98 - $75.72 $676,783 - $813,687
-10,746 Reduced 0.07%
15,787,987 $1.2 Billion
Q2 2019

Aug 12, 2019

SELL
$65.7 - $83.98 $1.06 Million - $1.36 Million
-16,166 Reduced 0.1%
15,798,733 $1.15 Billion
Q1 2019

May 14, 2019

SELL
$77.14 - $90.79 $8.22 Million - $9.67 Million
-106,534 Reduced 0.67%
15,814,899 $1.27 Billion
Q4 2018

Feb 11, 2019

BUY
$77.85 - $96.01 $3.24 Million - $4 Million
41,680 Added 0.26%
15,921,433 $1.47 Billion
Q3 2018

Nov 09, 2018

BUY
$88.91 - $98.84 $34 Million - $37.8 Million
382,597 Added 2.47%
15,879,753 $0
Q2 2018

Aug 06, 2018

SELL
$89.78 - $106.23 $96.8 Million - $115 Million
-1,078,202 Reduced 6.5%
15,497,156 $1.44 Billion
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $15.4 Million - $20.6 Million
-167,259 Reduced 1.0%
16,575,358 $1.57 Billion
Q4 2017

Feb 09, 2018

BUY
$89.56 - $98.21 $1.5 Billion - $1.64 Billion
16,742,617
16,742,617 $1.62 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.